ACRS EPS Estimates
Aclaris Therapeutics, Inc.
$3.77
+$0.29(+8.33%)
35
Overall
60
Value
9
Tech
36
Quality
Market Cap
$512.25M
Volume
3.50M
52W Range
$1.93 - $6.60
Target Price
$10.18
ACRS EPS estimates: the consensus estimate for Aclaris Therapeutics, Inc.'s current fiscal year is -$0.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ACRS EPS Estimates
- EPS estimate, current quarter
- $-0.16
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-0.62
- EPS estimate, next year
- $-0.65
- EPS growth, 3-year
- +26.41%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.53 |
| 2024 | $-1.71 |
| 2023 | $-1.27 |
| 2022 | $-1.33 |
| 2021 | $-1.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $3.77 | +8.3% | 3.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW